Beckman Coulter announced the DxA 5000 total laboratory automation solution has achieved European CE Mark and China FDA approval. In today’s healthcare environment, laboratories are highly focused on enhancing patient care by driving faster turnaround time (TAT), delivering quality results, and improving laboratory operations. The DxA 5000 helps laboratories meet these challenges through a collection of patented innovations that deliver rapid and consistent TAT, provide a new level of comprehensive pre-analytical sample quality detection, and reduce the number of manual processing steps to significantly improve laboratory efficiency.
Reporting results faster to physicians can positively impact patient outcomes. In the laboratory, specimen centrifugation is typically the most time-consuming pre-analytical activity. The DxA 5000 utilizes a universal centrifugation protocol that reduces the pre-analytical processing time by up to 73 percent for connected analyzers across multiple disciplines.
Additionally, the DxA 5000 supports laboratories in delivering highly consistent TATto their physicians. Leveraging first-of-its-kind dynamic system software, the DxA 5000 utilizes Intelligent Routing to bring automated patient-centric workflow to the laboratory. By understanding the tests requested, sample volume available and real-time analyzer capacity and status, the DxA 5000 continuously calculates the most expeditious route for every patient sample—both STAT and routine.
